Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Emery, P. et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 372, 375–382 (2008).
2. Breedveld, F. et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 54, 26–37 (2008).
3. Shahouri, S. H. et al. Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum. 63, 3204–3215 (2011).
4. Greenberg, J. D. et al. A comparative effectiveness study of adalimumb, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA Registry. Ann. Rheum. Dis. 71, 1134–1142 (2012).
5. Cohen, S. et al. Tofacitinib (CP-690550), an oral Janus kinase inhibitor: analysis of infections and all cause mortality across phase lll and long-term extension studies in patients with rheumatoid arthritis [abstract]. Arthritis Rheum. 63 (Suppl.), 409 (2011).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献